These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8494377)

  • 1. In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.
    Kimura M; Kishimoto T; Niki Y; Soejima R
    Antimicrob Agents Chemother; 1993 Apr; 37(4):801-3. PubMed ID: 8494377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.
    Miyashita N; Niki Y; Kishimoto T; Nakajima M; Matsushima T
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1331-4. PubMed ID: 9174194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.
    Nakata K; Okazaki Y; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1757-62. PubMed ID: 7986006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of garenoxacin against Chlamydia spp.
    Donati M; Pollini GM; Sparacino M; Fortugno MT; Laghi E; Cevenini R
    J Antimicrob Chemother; 2002 Sep; 50(3):407-10. PubMed ID: 12205067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp.
    Donati M; Rodrìguez Fermepin M; Olmo A; D'Apote L; Cevenini R
    J Antimicrob Chemother; 1999 Jun; 43(6):825-7. PubMed ID: 10404322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antichlamydial activities of HSR-903, a new fluoroquinolone antibiotic.
    Niki Y; Miyashita N; Kubota Y; Nakajima M; Matsushima T
    Antimicrob Agents Chemother; 1997 Apr; 41(4):857-9. PubMed ID: 9087506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.
    Nakata K; Maeda H; Fujii A; Arakawa S; Umezu K; Kamidono S
    Antimicrob Agents Chemother; 1992 Jan; 36(1):188-90. PubMed ID: 1317145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.
    Roblin PM; Montalban G; Hammerschlag MR
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1402-3. PubMed ID: 8092845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo activities of sitafloxacin against Chlamydia spp.
    Miyashita N; Niki Y; Matsushima T
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3270-2. PubMed ID: 11600398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia.
    Niki Y; Kimura M; Miyashita N; Soejima R
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2296-9. PubMed ID: 7840560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of quinolones in chlamydial infection.
    Oriel JD
    Rev Infect Dis; 1989; 11 Suppl 5():S1273-6. PubMed ID: 2672254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antichlamydial activity of ofloxacin.
    Hirai K; Une T
    Microbiol Immunol; 1986; 30(5):445-50. PubMed ID: 3462450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydial infections and the quinolones.
    Ronald AR; Peeling RW
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):351-4. PubMed ID: 1864296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How useful is the Chlamydia micro-immunofluorescence (MIF) test for the gynaecologist?
    Wagenvoort JH; Koumans D; van de Cruijs M
    Eur J Obstet Gynecol Reprod Biol; 1999 May; 84(1):13-5. PubMed ID: 10413220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    J Antimicrob Chemother; 1999 Oct; 44(4):549-51. PubMed ID: 10588319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.
    Malay S; Roblin PM; Reznik T; Kutlin A; Hammerschlag MR
    Antimicrob Agents Chemother; 2002 Feb; 46(2):517-8. PubMed ID: 11796366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.
    Roblin PM; Reznik T; Kutlin A; Hammerschlag MR
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1135-6. PubMed ID: 12604555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.
    Roblin PM; Hammerschlag MR
    Int J Antimicrob Agents; 2000 Sep; 16(1):61-3. PubMed ID: 11185415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of quinolones against Chlamydia pneumoniae.
    Hammerschlag MR
    Drugs; 1999; 58 Suppl 2():78-81. PubMed ID: 10553711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of five quinolones against Chlamydia pneumoniae.
    Hammerschlag MR; Hyman CL; Roblin PM
    Antimicrob Agents Chemother; 1992 Mar; 36(3):682-3. PubMed ID: 1320366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.